OrthoPediatrics (NASDAQ:KIDS) Trading 6.1% Higher After Analyst Upgrade

OrthoPediatrics Corp. (NASDAQ:KIDS)’s share price was up 6.1% during mid-day trading on Tuesday after Piper Sandler raised their price target on the stock from $55.00 to $62.00. The company traded as high as $52.45 and last traded at $51.88. Approximately 1,516 shares traded hands during trading, a decline of 99% from the average daily volume of 211,870 shares. The stock had previously closed at $48.88.

Separately, Zacks Investment Research lowered OrthoPediatrics from a “hold” rating to a “sell” rating in a report on Friday, March 12th. One investment analyst has rated the stock with a sell rating and three have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $54.50.

In other news, Director David R. Pelizzon bought 3,700 shares of the business’s stock in a transaction that occurred on Monday, March 15th. The stock was acquired at an average cost of $46.50 per share, for a total transaction of $172,050.00. Following the completion of the purchase, the director now owns 20,900 shares of the company’s stock, valued at approximately $971,850. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Bernie B. Berry III sold 3,136 shares of the company’s stock in a transaction on Wednesday, January 27th. The shares were sold at an average price of $51.73, for a total value of $162,225.28. Following the completion of the transaction, the director now owns 40,481 shares of the company’s stock, valued at $2,094,082.13. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 47,686 shares of company stock valued at $2,589,408. Corporate insiders own 33.60% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Group One Trading L.P. acquired a new position in shares of OrthoPediatrics in the fourth quarter valued at $58,000. Strs Ohio acquired a new position in shares of OrthoPediatrics in the third quarter valued at $123,000. Jane Street Group LLC acquired a new position in shares of OrthoPediatrics in the fourth quarter valued at $201,000. Tudor Investment Corp Et Al acquired a new position in OrthoPediatrics during the fourth quarter worth $218,000. Finally, JPMorgan Chase & Co. raised its stake in OrthoPediatrics by 21.2% during the third quarter. JPMorgan Chase & Co. now owns 4,942 shares of the company’s stock worth $230,000 after acquiring an additional 866 shares in the last quarter. Institutional investors and hedge funds own 71.74% of the company’s stock.

The firm has a 50 day simple moving average of $50.21 and a 200-day simple moving average of $46.70. The stock has a market capitalization of $951.64 million, a price-to-earnings ratio of -33.62 and a beta of 0.67.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings data on Thursday, March 11th. The company reported ($0.73) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.46). OrthoPediatrics had a negative return on equity of 11.57% and a negative net margin of 34.26%. On average, equities research analysts anticipate that OrthoPediatrics Corp. will post -1.26 earnings per share for the current year.

OrthoPediatrics Company Profile (NASDAQ:KIDS)

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.

Featured Article: How can you know how many shares are floating?

Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.